Similar to BRCA1, a secondary mutation in BRCA2 has also been shown to restore the mutant BRCA2 reading frame into the wild-type reading frame in cisplatin-resistant ovarian cancer [39]. The gene discussed is BRCA2; the disease is ovarian cancer.